English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Tuesday, April 30, 2024
New Immuno-Oncology Research Project in Partnership With Merck Starts at the BioMed X Institute in Heidelberg
Tuesday, February 6, 2024
New T-FINDER Platform Provides Deep Insights Into T Cell Responses Against Novel Cancer Vaccine
Friday, December 22, 2023
BioMed X Institute and Ono Pharmaceutical Launch New Collaboration in Cancer Research
BioMed X 研究所与小野药品公司(Ono Pharmaceutical)在癌症研究领域启动新的合作
BioMed X 研究所與小野藥品公司(Ono Pharmaceutical)在癌症研究領域啟動新的合作
Tuesday, November 7, 2023
BioMed X Launches a New Call for Application in Autoimmune Disease Research
Wednesday, November 1, 2023
BioMed X and AbbVie Start New Research Project in the USA
Thursday, June 29, 2023
BioMed X Institute Starts Its First Research Project With Sanofi on Artificial Intelligence for Drug Development
BioMed X Institute Starts Its First Research Project With Sanofi on Artificial Intelligence for Drug Development
Thursday, April 27, 2023
BioMed X Launches XSeed Labs in the US with Boehringer Ingelheim - a New Model for Building an External Innovation Ecosystem on an Industry Campus

Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575